Lesion-based indicators predict long-term outcomes of pheochromocytoma and paraganglioma- SIZEPASS.

Helena Hanschell,Salvador Diaz-Cano, Alfredo Blanes,Nadia Talat,Gabriele Galatá,Simon Aylwin,Klaus Martin Schulte

Frontiers in endocrinology（2023）

引用 0|浏览3

暂无评分

摘要

The SIZEPASS>1000 criterion is a lesion-based, clinically available, simple and effective tool to predict malignant behavior of PPGLs independently of age, sex, location or mutation status.

查看译文

关键词

pheochromocytoma,paraganglioma–,lesion-based,long-term

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要